189 related articles for article (PubMed ID: 19966541)
21. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
[TBL] [Abstract][Full Text] [Related]
22. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
23. Berberine enhances the anti‑tumor activity of tamoxifen in drug‑sensitive MCF‑7 and drug‑resistant MCF‑7/TAM cells.
Wen C; Wu L; Fu L; Zhang X; Zhou H
Mol Med Rep; 2016 Sep; 14(3):2250-6. PubMed ID: 27432642
[TBL] [Abstract][Full Text] [Related]
24. Synergistic effects of tamoxifen and tranilast on VEGF and MMP-9 regulation in cultured human breast cancer cells.
Darakhshan S; Bidmeshkipour A; Khazaei M; Rabzia A; Ghanbari A
Asian Pac J Cancer Prev; 2013; 14(11):6869-74. PubMed ID: 24377619
[TBL] [Abstract][Full Text] [Related]
25. Equol enhances tamoxifen's anti-tumor activity by induction of caspase-mediated apoptosis in MCF-7 breast cancer cells.
Charalambous C; Pitta CA; Constantinou AI
BMC Cancer; 2013 May; 13():238. PubMed ID: 23675643
[TBL] [Abstract][Full Text] [Related]
26. Blockade of Rac1 activity induces G1 cell cycle arrest or apoptosis in breast cancer cells through downregulation of cyclin D1, survivin, and X-linked inhibitor of apoptosis protein.
Yoshida T; Zhang Y; Rivera Rosado LA; Chen J; Khan T; Moon SY; Zhang B
Mol Cancer Ther; 2010 Jun; 9(6):1657-68. PubMed ID: 20515940
[TBL] [Abstract][Full Text] [Related]
27. The anticancer effect of PQ1 in the MMTV-PyVT mouse model.
Shishido SN; Delahaye A; Beck A; Nguyen TA
Int J Cancer; 2014 Mar; 134(6):1474-83. PubMed ID: 24038078
[TBL] [Abstract][Full Text] [Related]
28. Endocrine therapy inhibits proliferation and migration, promotes apoptosis and suppresses survivin protein expression in colorectal cancer cells.
Ou QJ; Wu XJ; Peng JH; Zhang RX; Lu ZH; Jiang W; Zhang L; Pan ZZ; Wan DS; Fang YJ
Mol Med Rep; 2017 Nov; 16(5):5769-5778. PubMed ID: 28849238
[TBL] [Abstract][Full Text] [Related]
29. Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells.
Khamis AAA; Ali EMM; El-Moneim MAA; Abd-Alhaseeb MM; El-Magd MA; Salim EI
Biomed Pharmacother; 2018 Sep; 105():1335-1343. PubMed ID: 30021371
[TBL] [Abstract][Full Text] [Related]
30. Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells.
Abdallah ME; El-Readi MZ; Althubiti MA; Almaimani RA; Ismail AM; Idris S; Refaat B; Almalki WH; Babakr AT; Mukhtar MH; Abdalla AN; Idris OF
Molecules; 2020 Jul; 25(15):. PubMed ID: 32722075
[TBL] [Abstract][Full Text] [Related]
31. Involvement of mTOR and survivin inhibition in tamoxifen-induced apoptosis in human hepatoblastoma cell line HepG2.
Guo R; Wang T; Shen H; Ge HM; Sun J; Huang ZH; Shu YQ
Biomed Pharmacother; 2010 Apr; 64(4):249-53. PubMed ID: 19931998
[TBL] [Abstract][Full Text] [Related]
32. Combined crizotinib and endocrine drugs inhibit proliferation, migration, and colony formation of breast cancer cells via downregulation of MET and estrogen receptor.
Ayoub NM; Alkhalifa AE; Ibrahim DR; Alhusban A
Med Oncol; 2021 Jan; 38(1):8. PubMed ID: 33449292
[TBL] [Abstract][Full Text] [Related]
33. Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells.
Li Z; Wang N; Fang J; Huang J; Tian F; Li C; Xie F
Oncol Rep; 2012 Jun; 27(6):1879-86. PubMed ID: 22427054
[TBL] [Abstract][Full Text] [Related]
34. A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.
Hatkevich T; Ramos J; Santos-Sanchez I; Patel YM
Exp Cell Res; 2014 Oct; 327(2):331-9. PubMed ID: 24881818
[TBL] [Abstract][Full Text] [Related]
35. Estrogen and antiestrogen-dependent regulation of breast cancer cell proliferation in multicellular spheroids: Influence of cell microenvironment.
Truchet I; Jozan S; Baron S; Frongia C; Balaguer P; Richard-Foy H; Valette A
Int J Oncol; 2008 May; 32(5):1033-9. PubMed ID: 18425329
[TBL] [Abstract][Full Text] [Related]
36. Tamoxifen synergizes with 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1,2-diol} and 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, novel azaresveratrol analogs, in inhibiting the proliferation of breast cancer cells.
Ronghe A; Chatterjee A; Bhat NK; Padhye S; Bhat HK
Oncotarget; 2016 Aug; 7(32):51747-51762. PubMed ID: 27351134
[TBL] [Abstract][Full Text] [Related]
37. The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells.
Zhou QM; Wang S; Zhang H; Lu YY; Wang XF; Motoo Y; Su SB
Acta Pharmacol Sin; 2009 Dec; 30(12):1648-58. PubMed ID: 19960010
[TBL] [Abstract][Full Text] [Related]
38. Increase of gap junction activities in SW480 human colorectal cancer cells.
Bigelow K; Nguyen TA
BMC Cancer; 2014 Jul; 14():502. PubMed ID: 25008544
[TBL] [Abstract][Full Text] [Related]
39. Effect of vitamin E on tamoxifen-treated breast cancer cells.
Peralta EA; Viegas ML; Louis S; Engle DL; Dunnington GL
Surgery; 2006 Oct; 140(4):607-14; discussion 614-5. PubMed ID: 17011908
[TBL] [Abstract][Full Text] [Related]
40. [Down-regulation of mTOR activity and survivin expression during tamoxifen-induced apoptosis in hepatoblastoma cells].
Guo RH; Wang TS; Chen XF; Huang ZH; Shu YQ
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):903-6. PubMed ID: 21223797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
